Recettore della dopamina D1 (Italian Wikipedia)

Analysis of information sources in references of the Wikipedia article "Recettore della dopamina D1" in Italian language version.

refsWebsite

Global rank Italian rank

19doi.org

2^nd place

7^th place

13nih.gov

4^th place

9^th place

3oadoi.org

799^th place

22^nd place

3aspetjournals.org

6,663^rd place

5,217^th place

2wiley.com

222^nd place

243^rd place

1jneurosci.org

low place

8,404^th place

1nature.com

234^th place

226^th place

aspetjournals.org

jpet.aspetjournals.org

(EN) Jonathan D. Urban, William P. Clarke e Mark von Zastrow, Functional Selectivity and Classical Concepts of Quantitative Pharmacology, in Journal of Pharmacology and Experimental Therapeutics, vol. 320, n. 1, 1º gennaio 2007, pp. 1–13, DOI:10.1124/jpet.106.104463. URL consultato il 26 maggio 2017.
(EN) David M. Mottola, Jason D. Kilts e Mechelle M. Lewis, Functional Selectivity of Dopamine Receptor Agonists. I. Selective Activation of Postsynaptic Dopamine D2 Receptors Linked to Adenylate Cyclase, in Journal of Pharmacology and Experimental Therapeutics, vol. 301, n. 3, 1º giugno 2002, pp. 1166–1178, DOI:10.1124/jpet.301.3.1166. URL consultato il 26 maggio 2017.
(EN) Jason D. Kilts, Hilary S. Connery e Elaine G. Arrington, Functional Selectivity of Dopamine Receptor Agonists. II. Actions of Dihydrexidine in D2L Receptor-Transfected MN9D Cells and Pituitary Lactotrophs, in Journal of Pharmacology and Experimental Therapeutics, vol. 301, n. 3, 1º giugno 2002, pp. 1179–1189, DOI:10.1124/jpet.301.3.1179. URL consultato il 26 maggio 2017.

doi.org

dx.doi.org

Dearry A, Gingrich JA, Falardeau P, Fremeau RT, Bates MD, Caron MG, Molecular cloning and expression of the gene for a human D₁ dopamine receptor, in Nature, vol. 347, n. 6288, September 1990, pp. 72–6, DOI:10.1038/347072a0, PMID 2144334.
Zhou QY, Grandy DK, Thambi L, Kushner JA, Van Tol HH, Cone R, Pribnow D, Salon J, Bunzow JR, Civelli O, Cloning and expression of human and rat D₁dopamine receptors, in Nature, vol. 347, n. 6288, September 1990, pp. 76–80, DOI:10.1038/347076a0, PMID 2168520.
Sunahara RK, Niznik HB, Weiner DM, Stormann TM, Brann MR, Kennedy JL, Gelernter JE, Rozmahel R, Yang YL, Israel Y, Human dopamine D₁ receptor encoded by an intronless gene on chromosome 5, in Nature, vol. 347, n. 6288, September 1990, pp. 80–3, DOI:10.1038/347080a0, PMID 1975640.
Juan Pablo Cueva, Gianfabio Giorgioni e Russell A. Grubbs, trans-2,3-Dihydroxy-6a,7,8,12b-tetrahydro-6H-chromeno[3,4-c]isoquinoline: Synthesis, Resolution, and Preliminary Pharmacological Characterization of a New Dopamine D1 Receptor Full Agonist, in Journal of Medicinal Chemistry, vol. 49, n. 23, 1º novembre 2006, pp. 6848–6857, DOI:10.1021/jm0604979. URL consultato il 26 maggio 2017.
(EN) Jing Zhang, Bing Xiong e Xuechu Zhen, Dopamine D1 receptor ligands: Where are we now and where are we going, in Medicinal Research Reviews, vol. 29, n. 2, 1º marzo 2009, pp. 272–294, DOI:10.1002/med.20130, PMID 18642350. URL consultato il 13 marzo 2017.
(EN) Roger K. Sunahara, Hong-Chang Guan e Brian F. O'Dowd, Cloning of the gene for a human dopamine D5 receptor with higher affinity for dopamine than D1, in Nature, vol. 350, n. 6319, 18 aprile 1991, pp. 614–619, DOI:10.1038/350614a0, PMID 1.826.762. URL consultato il 13 marzo 2017.
Martin A. Lewis, Lisa Hunihan e John Watson, Discovery of D1 Dopamine Receptor Positive Allosteric Modulators: Characterization of Pharmacology and Identification of Residues that Regulate Species Selectivity, in The Journal of Pharmacology and Experimental Therapeutics, vol. 354, n. 3, 1º settembre 2015, pp. 340–349, DOI:10.1124/jpet.115.224071. URL consultato il 25 aprile 2017.
Daniel R Rosell, Lauren C Zaluda e Margaret M McClure, Effects of the D1 Dopamine Receptor Agonist Dihydrexidine (DAR-0100A) on Working Memory in Schizotypal Personality Disorder, in Neuropsychopharmacology, vol. 40, n. 2, 25 aprile 2017, pp. 446–453, DOI:10.1038/npp.2014.192, PMID 25074637.
(EN) William J. Giardina e Michael Williams, Adrogolide HCl (ABT-431; DAS-431), a Prodrug of the Dopamine D1 Receptor Agonist, A-86929: Preclinical Pharmacology and Clinical Data, in CNS Drug Reviews, vol. 7, n. 3, 1º settembre 2001, pp. 305–316, DOI:10.1111/j.1527-3458.2001.tb00201.x. URL consultato il 25 aprile 2017.
Michael R. Michaelides, Yufeng Hong e Stanley DiDomenico, (5aR,11bS)-4,5,5a,6,7,11b-Hexahydro-2-propyl-3-thia-5-azacyclopent-1-ena[c]phenanthrene-9,10-diol (A-86929): a potent and selective dopamine D1 agonist that maintain behavioral efficacy following repeated administration and characterization of its diacetyl prodrug (ABT-431), in Journal of Medicinal Chemistry, vol. 38, n. 18, 1º settembre 1995, pp. 3445–3447, DOI:10.1021/jm00018a002. URL consultato il 26 maggio 2017.
Mitsuaki Yamashita, Ken-ichi Yamada e Kiyoshi Tomioka, Construction of Arene-Fused-Piperidine Motifs by Asymmetric Addition of 2-Trityloxymethylaryllithiums to Nitroalkenes: The Asymmetric Synthesis of a Dopamine D1 Full Agonist, A-86929, in Journal of the American Chemical Society, vol. 126, n. 7, 1º febbraio 2004, pp. 1954–1955, DOI:10.1021/ja031760n. URL consultato il 26 maggio 2017.
Qiwen Mu, Kevin Johnson e Paul S. Morgan, A single 20 mg dose of the full D1 dopamine agonist dihydrexidine (DAR-0100) increases prefrontal perfusion in schizophrenia, in Schizophrenia Research, vol. 94, n. 1-3, 1º agosto 2007, pp. 332–341, DOI:10.1016/j.schres.2007.03.033. URL consultato il 26 maggio 2017.
Mark S. George, Christine E. Molnar e Emily L. Grenesko, A single 20 mg dose of dihydrexidine (DAR-0100), a full dopamine D1 agonist, is safe and tolerated in patients with schizophrenia, in Schizophrenia Research, vol. 93, n. 1-3, 1º luglio 2007, pp. 42–50, DOI:10.1016/j.schres.2007.03.011. URL consultato il 26 maggio 2017.
(EN) Jane R. Taylor, Matthew S. Lawrence e D.Eugene Redmond, Dihydrexidine, a full dopamine D1 agonist, reduces MPTP-ioduced parkinsonism in monkeys, in European Journal of Pharmacology, vol. 199, n. 3, pp. 389–391, DOI:10.1016/0014-2999(91)90508-n. URL consultato il 26 maggio 2017.
(EN) Jonathan D. Urban, William P. Clarke e Mark von Zastrow, Functional Selectivity and Classical Concepts of Quantitative Pharmacology, in Journal of Pharmacology and Experimental Therapeutics, vol. 320, n. 1, 1º gennaio 2007, pp. 1–13, DOI:10.1124/jpet.106.104463. URL consultato il 26 maggio 2017.
(EN) David M. Mottola, Jason D. Kilts e Mechelle M. Lewis, Functional Selectivity of Dopamine Receptor Agonists. I. Selective Activation of Postsynaptic Dopamine D2 Receptors Linked to Adenylate Cyclase, in Journal of Pharmacology and Experimental Therapeutics, vol. 301, n. 3, 1º giugno 2002, pp. 1166–1178, DOI:10.1124/jpet.301.3.1166. URL consultato il 26 maggio 2017.
(EN) Jason D. Kilts, Hilary S. Connery e Elaine G. Arrington, Functional Selectivity of Dopamine Receptor Agonists. II. Actions of Dihydrexidine in D2L Receptor-Transfected MN9D Cells and Pituitary Lactotrophs, in Journal of Pharmacology and Experimental Therapeutics, vol. 301, n. 3, 1º giugno 2002, pp. 1179–1189, DOI:10.1124/jpet.301.3.1179. URL consultato il 26 maggio 2017.
Lisa A. Bonner, Benjamin R. Chemel e Val J. Watts, Facile Synthesis of Octahydrobenzo[h]isoquinolines: Novel and Highly Potent D1 Dopamine Agonists, in Bioorganic & medicinal chemistry, vol. 18, n. 18, 15 settembre 2010, pp. 6763–6770, DOI:10.1016/j.bmc.2010.07.052. URL consultato il 26 maggio 2017.

doi.org

(EN) Jane R. Taylor, Matthew S. Lawrence e D.Eugene Redmond, Dihydrexidine, a full dopamine D1 agonist, reduces MPTP-ioduced parkinsonism in monkeys, in European Journal of Pharmacology, vol. 199, n. 3, pp. 389–391, DOI:10.1016/0014-2999(91)90508-n. URL consultato il 26 maggio 2017.

jneurosci.org

ML Paul, AM Graybiel, JC David e HA Robertson, D1-like and D2-like dopamine receptors synergistically activate rotation and c-fos expression in the dopamine-depleted striatum in a rat model of Parkinson's disease, in The Journal of Neuroscience, vol. 12, n. 10, 1992, pp. 3729–3742.

nature.com

(EN) Roger K. Sunahara, Hong-Chang Guan e Brian F. O'Dowd, Cloning of the gene for a human dopamine D5 receptor with higher affinity for dopamine than D1, in Nature, vol. 350, n. 6319, 18 aprile 1991, pp. 614–619, DOI:10.1038/350614a0, PMID 1.826.762. URL consultato il 13 marzo 2017.

nih.gov

ncbi.nlm.nih.gov

Dearry A, Gingrich JA, Falardeau P, Fremeau RT, Bates MD, Caron MG, Molecular cloning and expression of the gene for a human D₁ dopamine receptor, in Nature, vol. 347, n. 6288, September 1990, pp. 72–6, DOI:10.1038/347072a0, PMID 2144334.
Zhou QY, Grandy DK, Thambi L, Kushner JA, Van Tol HH, Cone R, Pribnow D, Salon J, Bunzow JR, Civelli O, Cloning and expression of human and rat D₁dopamine receptors, in Nature, vol. 347, n. 6288, September 1990, pp. 76–80, DOI:10.1038/347076a0, PMID 2168520.
Sunahara RK, Niznik HB, Weiner DM, Stormann TM, Brann MR, Kennedy JL, Gelernter JE, Rozmahel R, Yang YL, Israel Y, Human dopamine D₁ receptor encoded by an intronless gene on chromosome 5, in Nature, vol. 347, n. 6288, September 1990, pp. 80–3, DOI:10.1038/347080a0, PMID 1975640.
Entrez Gene: DRD1 dopamine receptor D₁, su ncbi.nlm.nih.gov.
M. R. Michaelides, Y. Hong e S. DiDomenico, (5aR,11bS)-4,5,5a,6,7,11b-hexahydro-2-propyl-3-thia-5-azacyclopent-1- ena[c]-phenanthrene-9,10-diol (A-86929): a potent and selective dopamine D1 agonist that maintains behavioral efficacy following repeated administration and characterization of its diacetyl prodrug (ABT-431), in Journal of Medicinal Chemistry, vol. 38, n. 18, 1º settembre 1995, pp. 3445–3447. URL consultato il 26 maggio 2017.
(EN) Jing Zhang, Bing Xiong e Xuechu Zhen, Dopamine D1 receptor ligands: Where are we now and where are we going, in Medicinal Research Reviews, vol. 29, n. 2, 1º marzo 2009, pp. 272–294, DOI:10.1002/med.20130, PMID 18642350. URL consultato il 13 marzo 2017.
(EN) Roger K. Sunahara, Hong-Chang Guan e Brian F. O'Dowd, Cloning of the gene for a human dopamine D5 receptor with higher affinity for dopamine than D1, in Nature, vol. 350, n. 6319, 18 aprile 1991, pp. 614–619, DOI:10.1038/350614a0, PMID 1.826.762. URL consultato il 13 marzo 2017.
Martin A. Lewis, Lisa Hunihan e John Watson, Discovery of D1 Dopamine Receptor Positive Allosteric Modulators: Characterization of Pharmacology and Identification of Residues that Regulate Species Selectivity, in The Journal of Pharmacology and Experimental Therapeutics, vol. 354, n. 3, 1º settembre 2015, pp. 340–349, DOI:10.1124/jpet.115.224071. URL consultato il 25 aprile 2017.
Daniel R Rosell, Lauren C Zaluda e Margaret M McClure, Effects of the D1 Dopamine Receptor Agonist Dihydrexidine (DAR-0100A) on Working Memory in Schizotypal Personality Disorder, in Neuropsychopharmacology, vol. 40, n. 2, 25 aprile 2017, pp. 446–453, DOI:10.1038/npp.2014.192, PMID 25074637.
P. J. Blanchet, J. Fang e M. Gillespie, Effects of the full dopamine D1 receptor agonist dihydrexidine in Parkinson's disease, in Clinical Neuropharmacology, vol. 21, n. 6, 1º novembre 1998, pp. 339–343. URL consultato il 25 aprile 2017.
Qiwen Mu, Kevin Johnson e Paul S. Morgan, A single 20 mg dose of the full D1 dopamine agonist dihydrexidine (DAR-0100) increases prefrontal perfusion in schizophrenia, in Schizophrenia Research, vol. 94, n. 1-3, 1º agosto 2007, pp. 332–341, DOI:10.1016/j.schres.2007.03.033. URL consultato il 26 maggio 2017.
Mark S. George, Christine E. Molnar e Emily L. Grenesko, A single 20 mg dose of dihydrexidine (DAR-0100), a full dopamine D1 agonist, is safe and tolerated in patients with schizophrenia, in Schizophrenia Research, vol. 93, n. 1-3, 1º luglio 2007, pp. 42–50, DOI:10.1016/j.schres.2007.03.011. URL consultato il 26 maggio 2017.
Lisa A. Bonner, Benjamin R. Chemel e Val J. Watts, Facile Synthesis of Octahydrobenzo[h]isoquinolines: Novel and Highly Potent D1 Dopamine Agonists, in Bioorganic & medicinal chemistry, vol. 18, n. 18, 15 settembre 2010, pp. 6763–6770, DOI:10.1016/j.bmc.2010.07.052. URL consultato il 26 maggio 2017.

oadoi.org

Dearry A, Gingrich JA, Falardeau P, Fremeau RT, Bates MD, Caron MG, Molecular cloning and expression of the gene for a human D₁ dopamine receptor, in Nature, vol. 347, n. 6288, September 1990, pp. 72–6, DOI:10.1038/347072a0, PMID 2144334.
Zhou QY, Grandy DK, Thambi L, Kushner JA, Van Tol HH, Cone R, Pribnow D, Salon J, Bunzow JR, Civelli O, Cloning and expression of human and rat D₁dopamine receptors, in Nature, vol. 347, n. 6288, September 1990, pp. 76–80, DOI:10.1038/347076a0, PMID 2168520.
Sunahara RK, Niznik HB, Weiner DM, Stormann TM, Brann MR, Kennedy JL, Gelernter JE, Rozmahel R, Yang YL, Israel Y, Human dopamine D₁ receptor encoded by an intronless gene on chromosome 5, in Nature, vol. 347, n. 6288, September 1990, pp. 80–3, DOI:10.1038/347080a0, PMID 1975640.

wiley.com

onlinelibrary.wiley.com

(EN) Jing Zhang, Bing Xiong e Xuechu Zhen, Dopamine D1 receptor ligands: Where are we now and where are we going, in Medicinal Research Reviews, vol. 29, n. 2, 1º marzo 2009, pp. 272–294, DOI:10.1002/med.20130, PMID 18642350. URL consultato il 13 marzo 2017.
(EN) William J. Giardina e Michael Williams, Adrogolide HCl (ABT-431; DAS-431), a Prodrug of the Dopamine D1 Receptor Agonist, A-86929: Preclinical Pharmacology and Clinical Data, in CNS Drug Reviews, vol. 7, n. 3, 1º settembre 2001, pp. 305–316, DOI:10.1111/j.1527-3458.2001.tb00201.x. URL consultato il 25 aprile 2017.